Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC
Clinical trial NCT07116577 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07116577
- Sponsor
- Jinan Central Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-31
- Primary completion
- 2027-08-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.